Imarat Tablet is a combination pharmaceutical formulation containing Diacerein 50 mg, Glucosamine Sulfate Potassium Chloride 750 mg, and Methyl Sulfonyl Methane (MSM) 250 mg, designed to support joint health and alleviate symptoms associated with osteoarthritis. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and chondroprotective properties by inhibiting interleukin-1 beta, thereby reducing cartilage degradation and promoting joint function. Glucosamine Sulfate Potassium Chloride serves as a vital substrate for the biosynthesis of glycosaminoglycans and proteoglycans, essential components of cartilage matrix, facilitating repair and maintenance of articular cartilage. Methyl Sulfonyl Methane, a naturally occurring organosulfur compound, contributes to the reduction of oxidative stress and inflammation, enhancing joint mobility and comfort. The synergistic action of these active ingredients in Imarat Tablet provides symptomatic relief from joint pain, stiffness, and swelling, improving overall joint flexibility and quality of life in patients with degenerative joint disorders. Imarat Tablet is indicated for the management of osteoarthritis and other degenerative joint conditions. It should be used under medical supervision, considering potential contraindications and drug interactions. Regular monitoring and adherence to prescribed dosage are essential to achieve optimal therapeutic outcomes while minimizing adverse effects.